Coromandel International to acquire 45% in Senegal firm for $19.6 mn
The Hindu
Additionally, the fertilizer maker will infuse $9.7 m loan in the rock phosphate mining company
Fertilizer maker Coromandel International is set to acquire 45% equity stake in Baobab Mining and Chemicals Corporation (BMCC), a rock phosphate mining firm based in Senegal, Africa, for $19.6 million (about ₹150 crore).
Besides the acquisition, there will be a loan infusion of a further $9.7 million (about ₹75 crore) into BMCC through wholly owned subsidiary Parry Chemicals, Coromandel said on Friday.
The move is aimed at helping strengthen backward integration and ensure long term supply security of rock phosphate, a key raw material in manufacturing of phosphoric acid, which in turn is used to make complex fertilizers, the company said. At full capacity, BMCC can meet up to one-third of the company’s rock phosphate requirement. The Senegal firm commenced active production from 2021 and has since stabilised its operations, it said.
The transaction, subject to the approval of the government of Senegal and satisfactory completion of conditions contained in the agreements, is expected to be completed in the second quarter of 2022-23.
A part of the Murugappa Group, Coromandel is the largest private phosphatic fertilizer manufacturer in India. It operates three units for manufacturing about 3 million tonne of phosphatic fertilizers. The company said it has strategic tie-ups with leading integrated players like Tifert (Tunisia) and Foskor (South Africa) for meeting phosphoric acid requirements. It has been also augmenting captive phosphoric acid production at Visakhapatnam plant and sourcing rock from various countries.
As part of a strategy to strengthen the value chain, Coromandel said it had been evaluating opportunities in the phosphate mining to secure its rock phosphate needs.
The investment in BMCC will be a step towards achieving long-term sustainability and supply security goals for meeting India’s fertilizer needs, said executive vice chairman Arun Alagappan.
Rupee hits all-time low at 85.20 against USD due to strong greenback, rising crude oil prices, and weak domestic markets.
Viatris faces U.S. FDA import alert for products from Indore plant, exceptions made for certain shortages.
xAI’s Grok may soon come to an iOS app as the company announced its Series C funding round of $6 billion.
Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.
Equity markets fluctuate as Sensex and Nifty rise initially, then fall; global markets and oil prices also discussed.
Microsoft has been working on adding internal and third-party AI models to power Microsoft 365 Copilot.
China's dominance in critical minerals poses supply chain vulnerabilities for India, US, and EU nations, requiring strategic diversification efforts.
India's controversial popcorn tax system sparks outrage and criticism, with opposition questioning the complex GST rates.
ICAI President investigates auditing lapses at Byju's, disciplinary committee probing, details undisclosed, part of ongoing investigations.
Sensex and Nifty rebound sharply after steep decline, driven by value buying, bluechip stocks, and global market rally.
AS-IT-IS Nutrition aims for ₹300 crore GMV in 2025 with ATOM range, endorsed by Ravindra Jadeja.